the defects occupied almost all of the skin of the dorsum of the foot, no significant contracture occurred during the maximum followup period of 9 years. The purpose of this paper is to describe the detailed healing courses of the two cases and to provide a guide for the non-surgical treatment of neonatal cases involving extensive extravasation-associated skin necrosis.
Patients and Methods

Case 1
A 5-day-old female infant (gestational age: 41 weeks, birth weight: 3512 g) was hospitalized in a neonatal intensive care unit due to meconium aspiration syndrome. An intravenous line was placed in the dorsum of the right foot to administer calcium gluconate. Extravasation occurred and resulted in skin necrosis covering almost all of the dorsal skin of the foot to reach the inter digital space distally and the lateral malleolus proximally (Figure 1 ). Eleven days after the extravasation, the patient was moved to our hospital. Although there was extensive damage to the skin of the dorsum, skin grafting was not performed. Instead, the patient was treated conservatively because the underlying tendons and bones were not exposed. The initial therapies performed were daily rinsing with saline solution, the daily application of gentamicin-containing ointment, and the covering of the affected area with a non-adherent gauze. The necrotic tissues were removed manually. Trafermin agent (Fiblast spray; Kaken Pharmaceutical Co, Ltd, Tokyo, Japan) was also applied topically to the raw area that resulted from the removal of the necrotic tissue. Debridement of almost all of the affected area was completed after 3 weeks. Around Week 5, the superficial layer was covered by fibrotic tissue; however, only partial granulation changes were observed. On day 75 after admission, the patient was discharged to receive home treatment from her mother. Complete wound closure was confirmed at 15 weeks after the extravasation. One month after the wound closure, hypertrophic changes occurred in the scar, especially in the middle of the dorsum of the foot. This hypertrophy showed regression during follow-up examinations, however, we performed no additional treatments (such as moisturization or compression). At one year after the extravasation, the scar was observed to have
Abstract
We herein describe two cases of non-surgical treatment for skin necrosis of the dorsum of the neonatal foot caused by extravasation. In both the cases, closure of the defects was achieved after 3 months of conservative treatment without any complications. Although the defects occupied almost all of the dorsal skin of the foot, no significant contracture disabling the toe or ankle occurred during the maximum follow-up period of 9 years. Non-surgical
Introduction
In neonatal care, extravasation is a clinical issue in which the accidental leakage of intravenous infusion fluid into the subcutaneous space causes damage to the skin around the infusion site. Both the skin and the subcutaneous tissues can be severely damaged, especially if cytotoxic drugs such as calcium, potassium or bicarbonate solutions leak out of the vein. Total skin necrosis is occasionally observed in serious cases [1] . If the necrosis is extensive, then immediate debridement followed by skin coverage would be indicated to avoid associated infection or to rescue the underlying organs from tissue dehydration. In addition, physicians usually consider skin resurfacing to be necessary in order to prevent future deformities or functional losses due to subsequent scar contracture [1] [2] [3] . Nevertheless, the possibility that surgery will worsen a neonate's general conditions often limits surgical indications.
Respecting the priority of conservative skin care for neonates, we treated two Japanese patients with extensive extravasation-associated skin necrosis of the dorsum of the foot without surgery. In both the cases, we were able to achieve closure of the skin defects that were caused by bedside debridement, after 3 months of conservative treatment and without any tendon exposure or infection. Although an atrioventricular septal defect in an18-day-old female infant (gestational age: 40 weeks, birth weight: 3082 g). The infusion fluid contained fentanyl, midazolam, and vecuronium bromide. The patient was referred to us 21 days after the injury. Although almost all of the dorsal skin of the left foot had already necrotized, the underlying tissues were not exposed. Similarly to Case 1, we chose a conservative treatment. The course of wound healing was almost the same as in Case 1 ( Figure 3) . The wound had completely closed at 14 weeks after the extravasation, leaving slight hypertrophic scarring. As was seen in Case 1, a gradual improvement of hypertrophic scar was observed during the 1-year follow-up examination.
Discussion
Extravasation is an inevitable issue in neonatal care. The rate of extravenous fluid leakage in the routine care of infants has been estimated to range from 23-63% [4] . Wilkins et al. reported that 3.8% of extravasations caused skin necrosis, which mostly occurred during parenteral nutrition infusion for premature neonates of 26 weeks gestation or less [5] . Small areas of skin necrosis can heal smoothly by maintaining a moisturized environment. When skin necrosis is extensive, however, surgical treatments such as skin grafting must be considered in order to avoid infection, shorten the treatment period and prevent subsequent scar contracture.
Skin necrosis on the dorsum of the hand or foot, which are the most common sites for infusion, has a risk of causing tendon exposure. The resection of the tendons may be necessary if infection or desiccation of the exposed tendons occur. To avoid this risk, a nearly debridement followed by the immediate covering of the affected area with a skin graft or flap is indicated, especially when a skin defect is relatively wide. Such surgical treatments, however, softened and flattened. At 9 years after the extravasation, the skin of the affected area had regained the physiological texture of the dorsum of the foot (Figure 2 ). There was no limitation to the range of the ankle joint. Although the skin was slightly tense in comparison to the contralateral foot, toe flexion was not impaired.
Case 2
Extravasation occurred during cardiac surgery to repair may be complicated by donor-site morbidity. Moreover, surgical stresses and anesthesia can become burdens to the health of neonates and worsen their general condition. In both of the above reported cases, the necrotic sites healed successfully within 4 months of the initial injury following conservative treatment, which included daily bedside debridement, followed by the application of wet dressings. As a result of this treatment, the necrotic tissues were gradually replaced by granulation. Several authors have emphasized the importance of moisturization for infant skin care because of the immaturity of the barrier function of infant skin [6, 7] . Acknowledging this importance, Moon et al. employed wet dressing in the treatment of their extravasation cases [8] .
Trafermin (Fiblast®) is a recombinant human basic fibroblast growth factor (bFGF), a cytokine that is known to stimulate the proliferation of fibroblasts and capillary endothelial cells and to promote angiogenesis during the wound healing process [9, 10] . In Japan, it has already been used clinically to treat skin ulcers. We therefore expected bFGF to have a potent effect in extensive skin defects of the dorsal foot. bFGF was administered once a day until wound closure was almost complete.
Interestingly, the time-course of the granulation changes of our two cases was almost the same (week 5). During the replacement process, no exposure or infection of the extensor tendons was encountered. Although the mechanism by which these results were achieved is unclear, these two successful experiences demonstrate that the conservative treatment of extravasation wounds is possible, even when the affected area is relatively large. Even in cases with a high risk of tendon exposure, such as the cases of extensive total skin necrosis that we experienced careful daily observation of the wound should be performed until the completion of granulation as long as the tendons are not exposed.
Even if skin defects can be closed through conservative treatment, a possibility exists that contracture due to wound constriction will affect the functional outcome. In spite of the presence of extensive areas of necrosis (over 80% of the dorsal surface of the foot), the present cases showed no functional complications, which could include limitation in the range of motion of the ankle or toe joint. Such complications are frequently seen in post-burn conditions of the foot. The sequential photos of the healing processes in the contraction of the wound led us to hypothesize that the high extensibility of the skin around the wound could contribute to lessening the risk of the limitation of joint motions. Indeed, the recovered dorsal skin just proximal to the toes showed prominent extension in the most recent photos (Figure 2) . In Case 1, there was no contracture requiring surgical treatment in the 9-year follow-up period. If scar contracture were to occur during further body growth, we would have to consider surgical treatments such as scar plasty or skin graft.
Thus far, no reports have so far demonstrated the long-term success of conservative treatment for extensive necrosis of the dorsum of the foot due to extravasation. This case report could therefore provide guidance to help medical staff members to manage cases of skin necrosis after intravenous leakage.
In conclusion, conservative treatment could be an alternative to surgery for treating extensive skin necrosis caused by extravasation in neonates. Meticulous wound care, including rinsing, daily debridement and careful observation could contribute to enhancing the healing potential of the skin of neonates. Further research is needed to establish the best treatment protocol for extravasation injury, including the prevention of extravasation itself, to prevent infection or invasive damage of the underlying tissues and to reduce the incidence of sequelae.
